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Abstract
Background: Rett Syndrome is a neurodevelopmental disorder almost exclusively affecting females, characterized
by a broad clinical spectrum of signs and symptoms and a peculiar course. The disease affects different body
systems: nervous, muscolo-skeletal, gastro-enteric. Moreover, part of the symptoms are related to the involvement
of the autonomic nervous system.
In the Tuscany Rett Center at Versilia Hospital, we collected data from 151 subjects with a clinical diagnosis of
classical or variant RTT syndrome. For each subject, we assessed the severity of the condition with clinical-rating
scales (ISS, PBZ), we quantified the performance of the autonomic nervous system, and we performed genetic
analysis. We used multivariate statistical analysis of the data to evaluate the relation between the different clinical
RTT forms, the cardiorespiratory phenotype, the different genetic mutations and the severity of the clinical picture.
Individuals were classified according to existing forms: Classical RTT and three atypical RTT: Z-RTT, Hanefeld,
Congenital. A correlation between C-Terminal deletions and lower severity of the clinical manifestations was
evident, in the previous literature, but, considering the analysis of autonomic behaviour, the original classification
can be enriched with a more accurate subdivision of Rett subgroups, which may be useful for early diagnosis.
Results: Present data emphasize some differences, not entirely described in the literature, among RTT variants. In
our cohort the Z-RTT variant cases show clinical features (communication, growth, epilepsy and development), well
documented by specific ISS items, less severe, if compared to classical RTT and show autonomic disorders, previously
not reported in the literature. In this form epilepsy is rarely present. In contrast, Hanefeld variant shows the constant
presence of epilepsy which has an earlier onset In Hanefeld variant the frequency of apneas was rare and, among the
cardiorespiratory phenotypes, the feeble type is lacking.
Conclusion: A quantitative analysis of the different autonomic components reveals differences across typical and
atypical forms of RTT that leads to a more accurate classification of the groups. In our cohort of RTT individuals, the
inclusion of autonomic parameter in the classification leads to an improved diagnosis at earlier stages of development.
Keywords: RTT: Rett syndrome, MECP2: Methyl CpG binding protein 2, CDKL5: Cyclin dependent kinase-like 5, FOXG1:
Forkhead box G1, Z-RTT: Preserved speech variant or “Zappella variant”, ARTT-NOS: Atypical RTT-not otherwise specified
Abbreviations: ARTT-NOS, atypical RTT-not otherwise specified; BMI, body mass index; Brain, autonomic function;
CDKL5, cyclin dependent kinase-like 5; CORT, cortical; CVT, cardiac vagal tone; DEV, growth and development;
FOXG1, forkhead box g1; ISS, International Scoring System; MECP2, methyl CpG binding protein 2; MOV, movement;
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Z-RTT, preserved speech variant or “Zappella variant”
* Correspondence: giorgio.pini@uslnordovest.toscana.it; pinivg@gmail.com
1Tuscany Rett Center, Versilia Hospital, USL Toscana Nord Ovest, Pisa, Italy
5Versilia Hospital, via Aurelia 335, Camaiore, Tuscany, Italy
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Pini et al. Orphanet Journal of Rare Diseases  (2016) 11:132 
DOI 10.1186/s13023-016-0499-7
Background
Rett Syndrome (RTT) is a neurodevelopmental disorder
almost exclusively affecting females, characterized by a
broad clinical spectrum of signs and symptoms and a
peculiar course during life. It occurs with an average fre-
quency of about 1:10,000 in girls [1].
After the first identification of the gene in 1999 [2],
MECP2 mutations have been identified in 90–95 % of
the Classical RTT cases, where, after a period of appar-
ently normal neuropsychic development with some al-
terations in the general movements [3], individuals after
6–18 months present an arrest in their development
followed by a progressive deterioration of acquired skills
such as purposeful hand function and communication, a
deceleration of head growth, with the subsequent ap-
pearance of stereotypic hand movements. This syndrome
is associated with comorbidities including reduced som-
atic growth, gastro-intestinal problems, osteopenia, gait
apraxia, scoliosis, autonomic dysfunction, breathing dis-
turbances and frequent seizures.
According to the new revised criteria, it has been rec-
ognized that some individuals present many of the clin-
ical features of RTT, such as regression, but do not fit
the criteria established for the diagnosis of Classical
RTT [4]. These have been termed “atypical” RTT [5].
Among RTT atypical forms, some specific variants
have been described: Preserved Speech Variant or
“Zappella variant” (Z-RTT), characterized by milder clin-
ical abnormalities and by the appearance of some degree
of speech [6, 7]; the “Hanefeld variant” (CDKL5 gene re-
lated) in which there is a pathognomonic early onset of
seizures [8, 9]; the “Congenital variant” (FOXG1 gene re-
lated), with onset of the symptoms since after birth [10].
In these last two variants, the mutation and several clin-
ical features are notably different, hence they are consid-
ered as distinct clinical and molecular entities [11].
All these forms have different severity degrees in terms
of comorbidities, behaviour, prognosis and involvement
of the autonomic nervous system. The present study de-
scribes the clinical and autonomic features of the RTT
girls who attend the Tuscany Rett Center, in order to ob-
tain more information on the correlation between geno-
type and phenotype.
Methods
Our cohort consists of 151 individuals evaluated in the
Tuscany Rett Center, Versilia Hospital (Lido di
Camaiore, Italy) from January 2006 to April 2014. Dur-
ing the study six girls died due to complication of ill-
nesses or sudden death or because of drug resistant
infections.
Diagnosis of RTT (Classical, Atypical) was made by
two independent child neuropsychiatrists with expertise
on RTT, and individuals were categorized on the basis of
the RTT consensus revised criteria [4] 64.9 % of the girls
presented classic Rett, while 35.1 % presented atypical
RTT. 20 % of the individuals presented evident autistic
signs.
In our cohort all the forms described in the current
classification [4] were present, considering the wide vari-
ability of the RTT phenotype, the age of onset, the sever-
ity of impairments, and the clinical course. We also
observed some different type of “Rettoid” variants that
are now described as RTT spectrum, and were previ-
ously classified as “forme fruste”: late childhood regres-
sion variant, Rettoid Male, familial atypical variant [12].
In our cohort there are also individuals that can be
classified as atypical RTT, but they do not belong to any
of the specific forms. These individuals are two boys and
four girls with MECP2 mutations, one female with
MEF2C mutation and two girls with no mutation. These
individuals have been grouped in variant cases and they
will be referred to as Atypical RTT not otherwise speci-
fied (ARTT-NOS).
Phenotypic data were collected through clinical and
neurological evaluations. In all RTT cases, cardiorespira-
tory parameters and brain activity were investigated. For
each patient we assessed: clinical severity, cardiorespira-
tory parameters, brain activity, and genetic mutation.
Clinical assessment
For clinical assessment of the severity degree, all individ-
uals were evaluated using both the International Scoring
System (ISS) [13], and the Pini Bonuccelli Zappella scale:
PBZ [14].
International Scoring System (ISS): The ISS scale consists
of 21 items regarding the RTT typical features, divided in
five subscales: Growth and Development, Musculoskeletal,
Movement, Mental-Cortical and Brainstem-Autonomic.
Each item score ranges from 2 to 0 as follows: 2 severe
abnormality, 1: mild abnormality, 0: no abnormality.
Lower the score, the better the clinical condition. The
total score range between 0 and 15 has been considered
as mild, between 16 and 24 as moderate and above 24
as severe.
Pini Bonuccelli Zappella (PBZ): The PBZ scale takes
into account specific items about daily skills, and con-
sists in 26 items grouped into 3 functional domains:
movement (MOV): facial expressions, eye contact,
praxis, stereotipies, walking, sitting position, muscular
tone, tropism and dystonias and other movement disor-
ders; communication and sensitive (C-S) speech produc-
tion, comprehension, attention to visual, tactile, and
auditory stimuli, breathing, convulsions, appetite, sleep,
night-time sleep, day-time sleep, aggressivity; daily living
(DL) climbing and, descending stairs, feeding/swallow-
ing, feeding autonomy, falls unrelated to seizures. Each
item score ranges from 0 (normal) to 4 (more severe).
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The total score ranges between 0 and 23 (mild), 24–37
(moderate), 38–49 (severe) and > 49 (very severe). For the
abstract follow the link: http://rivistedigitali.erickson.it/
autismo/visualizza/articolo/11690/index.html.
Cardio-respiratory assessment
All the individuals have been investigated with the
Neuroscope system (Medifit Instruments Ltd, London,
UK) [15] to analyse their autonomic functions.
The NeuroScope™ employs VaguSoft software (MediFit
Diagnostics Ltd, London, UK), allowing to record simul-
taneously several autonomic cardiovascular and respira-
tory parameters non-invasively and synchronously with
EEG and video monitoring over a 1-h period. The auto-
nomic parameters included: cardiac vagal tone, heart
rate, transcutaneous blood gases (TCM4, Radiometer,
Copenhagen, Denmark), and respiratory patterns. Thirteen
abnormal, awake breathing rhythms have been identified
in the RTT syndrome: Breath hold, Central apnoea, Rapid
and shallow breathing, Hyperventilation, Tachypnoea,
Deep breathing, Biot’s breathing, Cheyne-Stokes breath-
ing, Regular breath holds, Protracted inspiration,
Atypical breathing, Shallow breathing and Valsalva’s
manoeuvre. Following analysis of the recording each
patient was assigned to a specific cardiorespiratory
phenotype according to the predominant pattern of re-
spiratory dysrhythmia [16].
Three abnormal breathing rhythms in the waking state
have been identified in the RTT population and cate-
gorised into Feeble, Forceful, and Apneustic type of
breathings. They constitute three unique cardiorespira-
tory phenotypes with different levels of blood gases,
autonomic tone, physical features, clinical complications
and idiosyncratic responses to drugs [17].
The cardio-respiratory assessment has been performed
in the Tuscany Rett Center only on individuals with con-
firmed clinical and genetic diagnosis.
Genetic analysis and mutations classification
Genetic analysis has been performed on all the individ-
uals with clinical RTT phenotype clinical presentation,
first for MECP2, (sequencing of the coding region and
Multiple Ligand Probe Amplification) and, whenever
negative or in case of early infantile onset epilepsy for
CDKL5. In two females FOXG1 and MEF2C molecular
analysis was performed upon specific clinical suspicion
[18, 19]. The majority of genetic tests have been per-
formed in different molecular laboratories. All MECP2
and CDKL5 mutations have been classified into 3 princi-
pal categories according to the nature of the sequence
variation and its subsequent effect on the protein se-
quence: substitutions (nonsense, missense), deletions
and frameshift. Among the frameshift mutations we fo-
cused on the mutations located in the C-terminal
segment of the gene. The group of the nonsense muta-
tions is furthermore divided into early truncating and
late truncating mutations according to the position of
the mutation in the gene [20].
Description of the sample and of the different clinical RTT
forms
Our sample consists of 151 individuals: 149 females and
2 males, 118 individuals present mutations in MECP2,
12 females are mutated in CDKL5, 1 in FOXG1 and 1 in
MEF2C. In 19 individuals all the molecular analysis re-
sulted negative. The mean age in our cohort is 12 years
(range 1–49, median 10).
Genetic tests and instrumental evaluations have been
performed in all individuals. However, for some few indi-
viduals, some data (like auxological parameters at birth
or development in the first year of life) were lacking.
This is the reason why the tables below have different
numbers.
The different clinical RTT forms in our sample are: 98
classical RTT (64.9 %) and 33 Atypical RTT (35.1 %).
Among the Atypical RTT cases, 19 females (12.6 %)
present with Z-RTT variant, 13 (8.6 %) with Hanefeld
variant, 1 (0.7 %) with congenital variant, and 20 cases
with ARTT-NOS variant (13.3 %). For each group we re-
port %, mean age at clinical evaluation, and mean age of
diagnosis (Table 1).
Statistical analysis
Data are described as mean and standard deviation (SD),
median and percentiles for continuous variables and as
absolute and relative frequencies for categorical variables.
Parametric analysis (ANOVA with Bonferroni) for
continuous variables and the χ2 test or Fisher’s exact test
for categorical variables, were used to measure differ-
ences between groups.
P value < or equal to 0.05 were considered statistically
significant and all P values were based on two tailed
tests. Statistical analysis was performed using STATA 9.0
for Windows (StataCorp, College Station, TX).
Table 1 Sample description—Clinical forms, age at the evaluation
and age at diagnosis
Clinical forms N. % Age at the evaluation
Mean (SD)
Age at the diagnosis
Mean (SD)
Classical 98 64,9 12,5 (10,2) 6,7 (8,5)
Z-RTT 19 12,6 12,5 (7,9) 7,3 (5,6)
Hanefeld 13 8,6 6,1 (4,8) 2,6 (1,7)
Congenital 1 0,7 2 1
ARTT-NOS 20 13,2 13,5 (9,5) 8,45 (4,8)
Total 151 100 – –
Pini et al. Orphanet Journal of Rare Diseases  (2016) 11:132 Page 3 of 16
Results
Evaluation with the International Scoring System (ISS)
The total ISS score has been calculated for 144/151
(95 %) RTT cases, since for 7/151 RTT cases the clinical
information was not complete (i.e. early growth and de-
velopmental data lacking). The mean total ISS score was
18.8. For classical forms (n = 98) ISS = 19.5 ± 5.9; Z-RTT
(n = 19) ISS = 11.7 ± 3.7; Hanefeld (n = 11) ISS = 19.4 ± 4.8;
Congenital (n = 1) ISS = 26; ARTT-NOS (n = 19) ISS =
21.4 ± 6. These differences are statistically significant
(F test = 9.33; p < 0.001) (Table 2) and confirm that
the Z-RTT females have the mildest presentation if
compared to all the other RTT forms [6].
ISS (subscales and items) and clinical forms
In order to evaluate the clinical severity of the common
features in the RTT disorder, a modified version of the
International Scoring System was used [16]. The ISS
scoring list consists of 21 features divided over five func-
tional domains: Growth and Development domain
(DEV); Musculoskeletal domain(M_SKEL); Movement
domain (MOV); Cortical domain(CORT), Autonomic
domain (BRAIN).
The oro-motor disturbances, initially considered part
of movement domain, were included in the Autonomic
domain, according to Julu and Witt Engerström [16].
The following tables show the ISS scores according to
the different functional domains in the different clinical
forms.
ISS subscales with statistical significance and clinical forms
a) Growth and development domain
All the auxological parameters: weight, height, head
circumference (OFC) and Body-Mass Index (BMI)
of all RTT cases were significantly reduced if
compared to the normal population but they were
higher in the Z-RTT variant (F test = 8.18; p < 0.005;
Table 3) than in the classical form and Hanefeld
variant (except for OFC). In fact in only the 5–10 %
of the Z-RTT variant cases, height, weight, OFC
were below the 3rd centile [21]. The ARTT-NOS
group presents, on the contrary, a major impairment
in growth if compared to the other forms.
We found a significant association between Rett
clinical forms and BMI (χ2 test = 19.54; p < 0.05). In
detail, the Z-RTT has a different centile distribution
if compared to other forms: classical, Hanefeld and
ARTT-NOS forms have a BMI lower than the 40th
centile in the majority of cases while the Z-RTT
have, in a large majority of cases (about 80 %) a BMI
above the 40th centile.
The BMI value was significantly higher in the
Z-RTT variant cases compared to the Classical and
the ARTT-NOS form (F test = 4.77; p < 0.005).
b) Musculoskeletal domain
This investigation considered three parameters:
muscular tone, contractions, and scoliosis. We
reported the data for the spinal curvature since is
the only parameters with significant differences
across clinical forms.
Scoliosis
In our sample, 85/151 subjects presented scoliosis.
Among these, the degree of scoliosis is severe in 31
(36 %) and mild in 54 (63 %); χ2 = 15.4, P = 0.052,
Table 4.
Scoliosis was more present in the RTT classical
sample if compared to the Z-RTT and to the Hanefeld
(χ2 test = 15.4; p = 0.05). In the subgroup of the RTT
not walking (28.5 %), the scoliosis was severe in the
50 % of the sample.
c) Movement domain
We analysed four main areas of motor function:
walking, use of hands, stereotypes and other
movement disorders (Table 5).
Walking ability
Since the walking can start either before or after
regression stage, and it can be lost in stage IV of
the disease, we reported the status at the stage of
evaluation.
Among the 151 subjects, 32 (21.2 %) were able to
walk without support, 76 (50.3 %) with support
and 43 (28.5 %) were not able to walk. We found
that females with Z-RTT variant were more able
to walk without support if compared to females
with classical and Hanefeld forms. Statistical
analysis revealed that only 5 % of Z-RTT girls
could not walk, while 45 % of Hanefeld cases could
not walk (χ2 test = 7.75; p = 0.021).
In the subgroup of the RTT not walking, the
scoliosis was severe in the 50 % of the sample.
Use of hands
The evaluation of use of hands ability revealed
that only the 3.3 % of the individuals were able to
adequately manipulate an object; 59.3 % could
grab and hold the object just for few seconds;
37.3 % of the cases did not have any purposeful
use of the hands.
Table 2 Clinical forms and ISS total score, percentage










Mean (SD) 19.5 (5.9) 11.7 (3.7) 19.4 (4.8) 26 21.4 (6)
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The dyspraxia was more severe in the group of the
classical RTT (43.4 %), ART-NOS (35 %) and
Hanefeld variant (38.5 %) compared to Z-RTT
(5.3 %), (χ2 test, p = 0.01), in Table 5. Even
considering the average across all the different
groups (42 %) Z-RTT females showed lower
impairment (5.3 %). Dispraxia was significantly
different in females with Z-RTT (5.3 %) versus
classic RTT (43 %) (χ2 test = 14.75, p = 0.001).
Stereotypies
The presence of stereotypies is particularly
important in the diagnosis of RTT syndrome.
Initially stereotypies are limited to bringing the
hand to the mouth, and later appear typical
bimanual stereotypies different from those
observed in autism.
Hand stereotypies were present in 135/148 RTT
subjects and had a higher occurrence in the RTT
classical forms than in all the variant forms: in
particular stereotypies were absent in only 4 % of
Classic RTT individuals, while 21 % of Z-RTT
females failed to show stereotypies (χ2 test = 6.87,
p = 0.032).
Other movement disorders (tremors, dystonia and
similar)
The 50.3 % of the RTT cases showed some
movement disorders, often tremor. In the 23.2 %
this tremor was mild, in the 0.7 % instead it was
sub-continuous and disabling. No significant
statistically differences were observed among the
groups.
d) Cortical domain
Cortical investigation is related to three main
parameters: intellectual disabilities, language
impairment and epilepsy. We analyzed intellectual
impairment, language and epilepsy. For epilepsy, we
considered its onset and its distribution across
clinical forms. For cognitive level and language, we
could only use two scores: profound or mild
impairment, since there were no girls with a “no
compromise” value. However there were some
Z-RTT girls able express themselves relatively well,
with extensive vocabulary and spontaneous
construction of sentences.
Speech
Since the first description of Andreas Rett one of
the key symptoms was the absence or loss of
speech. At the onset of the disease some children
had already developed a vocabulary of a few words
or even sentences with two words. To this stage
usually follows a stop phase and then regression,
however 12.6 % of females in our sample recovered
and amplified the vocabulary, using more than 10
words at age of 5; they constitute the Zappella
variant. In this form we recognized the presence of
moderate speech consisting of a few words, and
eventually the construction of complex sentences,
sometimes echolalic, sometimes purposeful, with an
extensive vocabulary. In some the language skills
extended to the understanding of writing.
Intellectual impairment
The disorder involves a significant cognitive
impairment, very difficult to quantify in standard
tests: the lack of speech and the eminent dyspraxia
implies that many assessments should be done
with eye tracking technology or other techniques
of augmentative and alternative communication
(AAC). These methods are incompatible with
short assessments, carried out in our sample.










<3rd centile 39 5 17 60
3rd–40th centile 48 47 58 15
>40th centile 13 48 25 25
Weight
<3rd centile 40 10 17 60
3rd–40th centile 35 21 58 20
>40th centile 25 69 25 20
OFC
<3rd centile 46 5 8 55
3rd–40th centile 39 27 50 30
>40th centile 15 68 42 15
BMI
<3rd centile 43 1 27 53
3rd–40th centile 23 16 45 16
>40th centile 34 79 27 31











No deviation 36.7 63.1 75 100 35
Mild 36.7 31.6 23.1 – 45
Severe 26.5 5.26 – – 20
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ISS discriminates between profound cognitive
impairment (IQ <20) and cognitive impairment
present but not profound (Q.I. between 20 and
70), because by definition there are no cases with
normal cognitive levels.
The distinction that we have arbitrarily used is the
acquisition of object consistency and attention to
language and images. According to this criteria we
distinguished a profound cognitive delay for
individuals with IQ <20, and a mild cognitive delay
in individuals with IQ between 20 and 70.
Z-RTT females showed minor globally impairment
that others groups (F test = 21.12; p < 0.001).
Epilepsy
We analysed epilepsy distribution and onset across
the clinical forms.
In the whole sample, epilepsy was present in
64.2 % of cases. Epilepsy was present in the
58.2 % of classical RTT cases and in all the cases
with the Hanefeld variant (100 %). Drug resistant
(completely or partial) epilepsy was present in
17.2 % of cases.
Furthermore, we observed that the drug resistant
epilepsies had progressively higher percentages in
the following order subgroups: Z-RTT variant
5.3 %; ARTT-NOS 15 % Classical RTT 17.4 % and
Hanefeld variant 38.5 %. Severe epilepsy was
present with major frequency in Hanefeld variant
if compared to the other clinical forms (15.3 %)
with χ2 test = 15.7; p < 0.05 (Table 6).
The median age of onset of epilepsy in the entire
sample was 50 months with a range between 1
and 216 months. An earlier onset epilepsy was
present peculiarly in the Hanefeld variant compared
to the other forms (F test = 9.38, p < 0.001) (Table 7).
e) Autonomic domain
The autonomic Nervous system is related to several
abnormalities: impaired swallowing, peripheral
circulation in limbs, mood disorders, sleep disorders,
abnormalities in the gastro-esophageal tract, urinary
bladder and cardio-respiratory abnormalities (see
below: Respiratory abnormalities and cardiorespiratory
phenotypes). Here we report gastro-enteric
dysfunction and sleep (Table 8).
Gastro-enteric disorders
RTT syndrome is often associated with nutritional
intake and growth problems. In general, feeding
difficulties are complex and involve oromotor,
behavioral, nutritional and medical components.
Oromotor problems may include: oropharyngeal
dysfunction, sensory defects, reduced mobility of
the tongue. One or all phases of the deglutition
function can be compromised.
Furthermore, breath disorders could disturb the
swallowing ability; drug used to control epilepsy
can induce lack of appetite, sedation and increase
Table 5 Movement domain and clinical forms
Walking % Classical (n= 97) % Z-RTT (n= 19) % Hanefeld (n = 13) % Congenital (n= 1) % ARTT-NOS (n= 20)
Walks 21.6 36.8 15.4 – 10
Walking impaired 50.5 57.9 38.5 – 55
Not walking 27.8 5.3 46.1 100 35
Use of hands % Classical (n= 97) % Z-RTT (n= 19) % Hanefeld (n = 13) % Congenital (n= 1) % ARTT-NOS (n= 20)
Normal 2 15.8 – – –
Reduced 54.6 78.9 61.5 – 65
No 43.4 5.3 38.5 100 35
Stereotypies % Classical (n= 95) % Z-RTT (n= 19) % Hanefeld (n = 13) % Congenital (n= 1) % ARTT-NOS (n= 20)
Absent 4.2 21.05 15.4 – 15
Mild 46.3 42.1 61.5 100 50
Dominant or constant 49.5 36.8 23.1 – 35
Table 6 Epilepsy and clinical forms
Epilepsy % Classical (n = 98) % Z-RTT (n = 19) % Hanefeld (n = 13) % Congenital (n = 1) % ARTT-NOS (n = 20)
Absent 41.8 36.8 – 100 25
Controlled by therapy 40.8 57.9 61.5 – 60
Barely or not controlled by therapy 17.4 5.3 38.5 – 15
Pini et al. Orphanet Journal of Rare Diseases  (2016) 11:132 Page 6 of 16
of drooling. Severe not treated constipation can
influence in a bad way the appetite too. In our
cohort use of PEG was rare (2 %).
The 38.9 % of the individuals did not present
dysphagia, 46.3 % presented dysphagia for solid
foods but not for liquid ones, while only the
14.7 % presented dysphagia for both. Among
Z-RTT females, nobody presented severe dysfagia
and in 58 % disfagia was absent. Sixty-two percent
individuals with Hanefeld variant presented
functional dysfunction with half individuals with
severe dysfunctions and half with mild dysfunctions.
There was a significant difference between groups
(χ2 test = 6.69; <0.035).
In our sample more than a half of the cases
(55.7 %) presented a mild irregular intestinal
rhythm and 18.1 % of individuals presented severe
constipation; many of these individuals needed drug
based approach. The Z-RTT females presented
constipation more rarely than the other groups.
Sleep
There is high prevalence of sleep problems in Rett
syndrome (80–94 % across different age groups).
Sleep problems were identified most frequently in
the younger age group. Daytime napping, night-time
laughter, teeth grinding, night screaming and seizures
were the problems most frequently reported. Some
specific sleep problems did appear to vary with age
with night laughing decreasing with age and daytime
napping increasing with age. Sleep dysfunction had
consequence on the whole family, hence in our
cohort we considered only the most severe cases
with sleep difficulties and early awakenings.
Sixty-one point seven percent of the individuals
did not present sleep disorders, the 24.8 %
presented occasional difficulties and only the
13.4 % of the cases needed drugs to treat them.
There was a significant statistical difference
(χ2 test = 17.7; p < 0.02, Table 9) in Z-RTT females
the sleep abnormalities were less severe.
The 69 % with Classical forms and Z-RTT did not
show any alteration in the sleep-awake rythm
compared to other subgroups (38 %).
We report cardio-respiratory abnormalities later,
since they are often misinterpreted by caregivers.
ISS areas and clinical forms
The results of the ISS components in the different
forms are reported below. The table was realized
with the individuals with reported scores for ISS
(Table 10).
Growth and development: Z-RTT showed a minor
deficit than all the other RTT form (F test = 8.18;
p < 0.005). Musculoskeletal appearance: Z-RTT
group was less affected than the Classical RTT
group (F test = 3.29; p < 0.05). Movement: the
motricity area was less compromised in the
Z-RTT if compared to the classical forms
(F test = 3.5; p < 0.005). Cortical: minor impairement
was observed for the group of Z-RTT if compared
to the ARTT-NOS, Hanefeld, (F test = 12.21;
p < 0.001). Autonomic system: no significant
differences among the single RTT clinical forms.
Altogether we confirmed that Z-RTT females have
lower scores as they have a milder clinical
presentation.
Evaluation with Pbz scoring system
PBZ and clinical forms
PBZ The PBZ is a scale of evaluation designed to test
severity in Classical Rett and its variants. PBZ scoring
scale, as ISS, considers motor performances and sensi-
tive and comunicative abilities (S-C), and in addition,
takes into account daily living. This scoring system has a












Mean (SD) 62.6 (43) 49.4 (11.7) 2.2 (1.6) – 49 (39.9)
Range 1–216 36–72 1–7 – 2–108
Table 8 Feeding problems and clinical forms
% Classical (n = 96) % Z-RTT (n = 19) % Hanefeld (n = 13) % Congenital (n = 1) % ARTT-NOS (n = 20)
Dysphagia
None 35.4 58 38.5 – 40
Mild 47.9 42 31 100 50
Severe 16.7 – 30.5 – 10
Constipation
None 23.9 47.4 23.1 – 20
Mild 59.4 36.8 53.8 100 55
Severe 16.7 15.8 23.1 – 25
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similar trend of ISS, but measures also daily living and it
is more sensible for the association analysis with genetic
mutations. The scale is susceptible to recording even
minimal changes in clinical symptoms over the course of
therapy, rehabilitation programmes and environmental
enrichment, but also to indicating the severity of differ-
ent clinical and genetic groups (Table 11).
Females with Hanefeld variant presented the worst
data for ISS and daily living.
Table 12 shows the various classes of PBZ for Classic
Rett and variants: the differences were all significant in
each area: Motor area: all forms were significantly more
severe than the Z-Rett (χ2 test = 40.53; p < 0.001). Commu-
nicative and sensory skill area (SC): in a total of 6 females
with Hanefeld presentation, 3 variant were severe and 3
very severe, and showed a significant difference versus all
other (χ2 test = 25.93; p < 0.01), while the Z-Rett rank
mainly between mild forms (50 %) and medium (36 %).
Daily living: the Hanefeld variants were placed in 33 %
of the serious and in 50 % among the worst forms; the
Z-Rett presented better than the other with significant
statistical difference (χ2 test = 25.04; p < 0.01).
Total: there were significant differences in the PBZ
scores between different forms: 71.4 % of Z-Rett girls
presented a mild score while the majority of the girls
presented a medium score (χ2 test = 39.35; p < 0.001).
Cardiorespiratory evaluation
Respiratory abnormalities and cardiorespiratory phenotypes
The originality of our study consists in the evaluation of
the autonomic system through the use of Neuroscope
which is non-invasive procedure, and provides important
information on respiratory and heart parameters, and
simultaneous video EEG registration electroencephalo-
graphic [15] RTT individuals who carried out the assess-
ment with the neuroscope were 135 /151.
Thirteen abnormal, awake breathing rhythms have been
identified in the RTT syndrome- see Methods section.
On the basis of the neurovegetative different features
(vagal tone, heart rate, etc..), of the data of the hemoga-
sanalysis and of the rate of the breath abnormalities, we
define three different cardiorespiratory phenotypes:
Apneustic, Feeble, Forceful [16]. Apneustic breathing is
characterized by the prevalence of fragmented breath, in
which isolated breath hold or regular and prolonged res-
piration dominate. Feeble breathing is characterized by
the prevalence of a superficial and fast respiration during
most of the time. Peculiarity of the Forceful breathing is
the prevalence of hyperpnea, tachypnea and deep respir-
ation. The recognition of the different cardiorespiratory
phenotypes is important since each of them determines
different metabolic consequences and determine differ-
ent treatments [17]. We performed additional statistical
analysis taking into account the age of the subjects in
the sample. We considered three age groups: 0–5 years,
6–14 years old, and over 14. We found that the cardiore-
spiratory phenotypes apneustico and forced were stable
over time, while the phenotype feeble increased signifi-
cantly (chi2 = 23:32 p = 0.001). This trend is in agree-
ment with data in literature [15] which showed that
individual respiratory abnormalities (hyperpnea, apneas
and breath hold) are more important in younger girls
and decline over time, while shallow more represented
in older females (third group).
Below we report the percentage of abnormal breathing
for each clinical form (Table 13).
There is no significant correlation between percent-
ages of abnormal breathing and clinical forms. Consid-
ered the importance of the breathing phenotype in RTT,
we investigated how different parameters correlate to











None 66.7 78.9 38.5 – 40
Mild 17.7 21.1 46.1 100 45
Severe 15.6 – 15.4 – 15
Table 10 ISS areas and clinical forms
ISS areas Classical Z-RTT Hanefeld Congenital ARTT-NOS
Development
(n = 144)
Mean (SD) 4.2 (2.6) 1.4 (1.4) 4.4 (2.6) 9 (−) 5.5 (2.8)
Range 0–8 0–5 2–8 – 0–9
M_SKEL
(n = 146)
Mean (SD) 2.6 (1.8) 1.2 (1.1) 1.5 (0.9) 2 (−) 2.4 (1.7)
Range 0–6 0–5 0–3 – 0–5
Movement
(n = 147)
Mean (SD) 4.6 (1.4) 3.4 (1.3) 4.5 (1.1) 6 (−) 4.5 (1.5)
Range 0–8 1–6 3–6 – 2–8
Cortical
(n = 146)
Mean (SD) 3.8 (1.1) 2.5 (0.8) 5.1 (1) 4 (−) 3.9 (0.9)
Range 1–6 1–5 3–6 – 3–6
Brain
(n = 146)
Mean (SD) 4.3 (2) 3.3 (1.8) 4.5 (1.8) 5 (−) 5.1 (2.4)
Range 1–9 0–7 2–8 – 1–10
Pini et al. Orphanet Journal of Rare Diseases  (2016) 11:132 Page 8 of 16
the breathing phenotype starting with BMI. For each pa-
tient, we correlated the breathing phenotype determined
with clinical assessment with the BMI (Table 14).
The comparison among cardiorespiratory phenotypes
and BMI was not statistically significant (χ2 test = 2.13;
p = 0.71), however in the majority of cases (42 %) the
forced phenotype presented a pathological BMI (<3rd
centile).
Cardiorespiratory phenotype and clinical forms
We considered the different cardiorespiratory phenotype
in the different RTT clinical forms, and we noticed that
all the respiratory abnormalities are represented in all
the RTT groups but in Hanefeld variant, where we found
mainly hyperpnea, tachypnea and breath-hold, while the
Feeble Phenotype was lacking.
The distribution of the different cardiorespiratory phe-
notypes in the sample (n = 134) was the following:
apneustic n = 14 (10.4 %), feeble n = 52 (39.5 %) and
forceful n = 66, (48.5 %). In three cases no pathological
abnormalities were present and in one case the results
of the analysis were not evaluable.
Seventeen individuals could not be assessed for tech-
nical issues (Table 15).
In only one classical RTT and in 2 ARTT-NOS cases
no respiratory abnormalities were recorded. The follow-
ing tables refer only to cases with a complete autonomic
evaluation. There were no cases of Feeble phenotype in
females with Hanefeld presentation.
Single parameters in cardio-respiratory phenotype
We looked at specific abnormalities in all the groups
considered: Tachipnea, Iperventilation, Breath-hold, ab-
normal breathing, Valsalva Maneuver, cardiac parame-
ters (HR and CVT) and transcutaneous parameters
(PO2 e PCO2) (Table 16).
Valsalva maneuver was independent from the cardio-
respiratory phenotype. In the unique case of congenital
RTT, no Valsalva’s was recorded. Valsalva’s was more
common in the classical form and even so predominant
to hide the cardiorespiratory phenotype [16].
Cardiac activity We also looked at the cardiac activity,
and the vagal tone (Tables 17, 18, 19 and 20).
There was a significant difference between forceful
and feeble fenotype (F test = 3.08; P < 0.005).
The average heart rate frequency recorded in our
protocol was 96.7 bpm. We did not find significant
differences.
The average value at rest for vagal tone (CTV) was
5.88.
We found differences in the CVT among different
groups, with a significant abnormality in feeble and
apneustic versus forced (F = 5.80; P <0.005 Anova with
Bonferroni). Individuals with forced phenotype showed
values closer to standard [15].
Individuals with forced phenotype had the lowest
values of both PO2 (means 90.2; SD 13.3), and PCO2
(means 33.5; SD 12.8); while the weak phenotype and
Table 11 PBZ areas mean scores and clinical forms
PBZ score Classical Z-RTT Hanefeld Congenital ARTT-NOS
Motor area Mean (SD) 13.3 (4.6) 6.4 (3.8) 16.3 (4.5) 0 (−) 11.8 (2.3)
Range 5–24 0–15 12–22 – 8–14
S-C Mean (SD) 12.2 (4.6) 8 (4.1) 21.5 (5.7) – 14.2 (5.9)
Range 3–23 1–15 16–32 – 8–25
Daily living Mean (SD) 10.2 8 (3.4) 5.4 (3.4) 11.8 (2.7) – 7.7 (2.8)
Range 1–17 0–11 7–15 – 4–13
Total Mean (SD) 35.7 (9.8) 19.8 (10.3) 49.7 (11.2) – 33.7 (6)
Range 13–62 2–41 40–69 – 27–44
Table 12 PBZ and severity in clinical forms, percentage
PBZ areas Severity scale Classical Z-RTT Hanefeld ARTT-NOS
Motor
(0–36)
Mild 3.8 50 – –
Medium 40.4 42.9 – 40
Severe 40.4 7.1 50 60
Extreme 15.4 – 50 –
S-C
(0–48)
Mild 17.3 50 – –
Medium 40.4 35.7 – 50
Severe 34.6 14.3 50 30
Extreme 7.7 – 50 20
Daily living
(0–20)
Mild 7.7 42.9 – 20
Medium 30.8 42.9 16.7 60
Severe 44.02 14.3 33.3 10
Extreme 17.3 – 50 10
Total
(0–104)
Mild 9.6 71,4 – –
Medium 82.7 28.6 66.7 100
Severe 7.7 – 33.3 –
Extreme – – – –
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the apneustic phenotype had on average the highest
levels of PCO2 and sometimes episodes of hypercapnia.
Genetics
1- General consideration
In the majority of cases (132 cases, 87,4 % of the
subjects of the sample), the genetic mutation
causative of the clinical picture was identified; in 19
cases (12,6 %) all the molecular analysis (of the
MECP2 gene and, in case of evocative phenotype, of
the CDKL5 gene) resulted negative.
Among the 132 mutated cases, a MECP2 gene
mutation was identified in 118 (89.4 %); 116 are
females and 2 are males. In this group we found: 42
cases with missense mutations (36 %), 31 cases with
nonsense mutations (26 %), 28 with frameshift
mutation (24 %) and 17 with large deletions (14 %).
In particular the mutations identified in the two
males were one missense mutation (p. Arg306His, in
a mosaic state) and one frameshift (p. G269fs).
Furthermore, there were 12 cases with a mutation in
the CDKL5 gene (9.0 %), 1 case with a mutation in
FOXG1 (0.75 %) and 1 case with a mutation in
MEF2C (0.75 %).
In this study we found a significant correlation
between C-terminal and the Z-RETT variant [21].
2- Different clinical RTT forms and genes involved
(Table 21)
Among the classical RTT and the Z-RTT, a MECP2
mutation was found in almost the majority (respectively
96 % for classical and 95 % for Z-RTT) of the cases. In
the last 4 cases of classical RTTand 1 case of Z-RTT
noMECP2 or CDKL5 mutations were found.
We did not find MECP2 mutations in cases with
either congenital or Hanefeld variant. The only
congenital RTT had a FOXG1 mutation and all the
Hanefeld RTT variant cases had CDKL5 mutation,
confirming the correlation between CDKL5 mutations
and Hanefeld variant.
In the group of the ARTT-NOS, a MECP2 mutation
was identified in only 6/20 (30 %) of the cases,
suggesting that this group is probably heterogeneous
in term of etiology.
In individuals of the ARTT-NOS group, the MECP2
positive girls had a very early onset of the neurological
symptoms without evidence of regression. The
mutations identified in this group were: p. Arg106Trp,
p. Pro251Arg, p. Arg255Ter. p. G269fs.
3- MECP2 positive cases and RTT clinical forms
In the whole sample, almost all the mutations types
were represented (Table 21): the most frequent
mutations group were the missense mutations and
the less frequent were large deletions.
The frameshift mutations, are mostly (68 %) in the
C terminal region (Table 22).
We did not observe any significant statistical
correlation among the different MECP2 mutations
and the different RTT clinical forms, with the
exception of the predominance of C-terminal
deletions in Z-RTT variants.
In our sample, the eight recurrent mutations
(p. Arg106Trp, p. Arg133Cys, p. Thr158Met;
p. Arg168Ter; p. Arg255Ter; p. Arg270Ter,
p. Arg294Ter, p. Arg306Cys) representing in
literature about the 80 % of the MECP2 mutations
[20], account for about 47 % of the total RTT
MECP2 mutated cases. Among the differents RTT
clinical forms, in our sample the majority (60 %) of
the p. Arg106Trp cases had a clinical picture
fulfilling the criteria for Z-RTT.
About the other types of mutations, we found a
relative higher frequency of large deletions (14 % of
cases, all in classical RTT) and C terminal deletions
(16 % of cases).
Table 13 Abnormal breathing and clinical forms










Mean (SD) 50.8 (21.4) 41.7 (17.7) 57.1 (23.1) 37.4 42.5 (24.4)
Range 0–100 3–71.5 17.2–84.4 – 0–77







<3rd centile 30 % 34 % 42 %
3rd centile–40th centile 35 % 22 % 14 %
>40th centile 35 % 44 % 23 %











Feeble 37 % 53 % – – 50 %
Forceful 49 % 42 % 80 % 100 % 39 %
Apneustic 13 % 5 % 20 % – –
Normal 1 % – – – 11 %
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c) MECP2 mutations and ISS
Statistical analysis showed that ISS score is lower in
the group of the C terminal deletions RTT girls if
compared to the other mutations groups [21]
(Table 23).
No other significant correlations was found among
other type of mutations (early truncating mutations,
late truncating mutations, deletions) and ISS clinical
score.
We investigated correlation between different
MECP2 mutations and the ISS scores, and we found
a significant correlation between C-Terminal
mutations and ISS domains development and
autonomic functions:
Development: 77 % of the mutations terminals C had
a mild severity (ISS) for domain DEV (development
and growth) while all other mutations were mild
only in 33 % of cases (test χ2 = 7.63; p < 0.05).
Autonomic system: 72 % of cases C term were
mild compared to 33 % of other (χ2 test = 9.78;
p < 0.01).
Total: 78 % of cases the term C had a mild form
versus 24 % of other forms (χ2 test = 3.20; p < 0.001).
d) MECP2 mutations and PBZ
Like for ISS, we found that showed that the group of
the C terminal deletions RTT girls has lower PBZ
score if compared to the other mutations groups.
This is true for the total score and the motor
abilities (Table 24).
MOTOR abilities: 57 % of the C terminal del. cases
had a milder presentation (19 %) compared to other
groups (χ2 test = 28.52, p < 0.05).
DAILY LIVING: 86 % of C terminal del. cases had
mild or medium presentation.
TOTAL score PBZ: 50 % of C terminal del. cases
had a presentation mild–medium versus 13 % of the
non C terminal del. forms (χ2test = 9.77, p < 0.01).
e) MECP2 C terminal deletion phenotype
Overall we had 19/118 cases with a C terminal
deletion. Twelve of them (63 %) had a RTT
classical form and seven (37 %) had a Z-RTT
form [6, 22, 23].
The age-range is from 2 to 20 years. Growth
parameters were in the normal range in almost all
the girls (except one case for which data are not
available). OFC was in the normal range in about
10/19 cases, in 6/19 between the 3rd and 40 %
centile and only in 2 cases females showed clear
microencephaly.
Total ISS score evaluation showed for C terminal
deletion cases the majority (13/19) had a mild score,
4/19 case had a moderate score and in 1/19 case a
severe score. Epilepsy was absent in 8/19 cases,
present but drug controlled in 10/19 cases and only
in 1/19 case the epilepsy was drug resistant. Scoliosis
was absent in the 8/19 cases and present but of a
mild degree in 7 cases. No one RTT girls needed a
surgical intervention for scoliosis. Only 4/19 were
not able to walk, while 9/19 walked with a support
and 6/19 were able to walk alone.
Tremors or tremors like were present in half of this
sample. In almost all cases, hands stereotypies were
present but non dominant. In 6 of them (range 7–20
years of age), all with Z-RTT, the language was
composed by >20 words. The cardiorespiratory
phenotype was forced in 9 cases, feeble in 8 cases,
and apneustic in 1 case; 1 case was not analysed.
4- CDKL5 positive cases
Overall we had 13/151 cases with Hanefeld
variant who all but one presented CDKL5 gene
mutations. All the cases belonging to this group
can be defined as Hanefeld variant RTT. They
had a age-range of 1–12 years with a mean age of
about 6 years.
Total ISS total score evaluation showed that
Hanefeld variants had higher severity than all the
other RTT forms. According to the PBZ evaluation
scales, the scores for the CDKL5 cases were higher
(severe) than the MECP2 one (F test = 3.18;
p < 0.005) and this is mainly regarding the sensorial











Mean (SD) 5.5 (9.8) 0.6 (0.7) 1.3 (1.9) 0.2 (−) 3 (7.8)
Range 0–53.2 0–2.1 0–6.8 – 0–32.8









Mean (SD) 98.9 (15.8) 91.3 (15.7) 101.2 (17.4) 90
Range 74–137.4 55–130 54–148 –











Mean (SD) 95.6 (16) 94.2 (14.4) 105.2 (24.6) 148 (−) 97.6 (13.6)
Range 55–130 65–115 54–137,4 – 78–126











Mean (SD) 5.6 (3.5) 5.9 (2.4) 6.1 (7.7) 0.7 (−) 6.4 (3.4)
Range 1.2–20 3–13.1 0.9–28.9 – 1.9–15
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and communicating abilities (F test = 5.88; p < 0.005)
and Dayly living.
Considering the ISS different subscales, the
Muscolo-skeletal area was the most affected if
compared to the others. In the growth domain, both
height and weight were in the normal range in the
majority of cases (with the height at the upper
centile). OFC was below the 3rd centile in 8 % of
cases, a portion comparable with what have been
observed in Z-RTT. BMI was better than what
observed in all the RTT form (with the exception of
the Z-RTT which is less compromised). Scoliosis
was absent in the majority of cases (75 %).
Walking was difficulty in about 84 % of cases, of
which half of them was not able to walk without
support. Hand stereotypies, mainly of mild degree,
were present in all the samples. Hand dyspraxia was
more severe in the group of the Hanefeld variant
(together with classical RTT, ART-NOS) if compared
to the Z-RTT.
Epilepsy was present in all the cases (100 %) and
there was a higher percentage of drug resistant cases
compared to all the other RTT subgroups. The
median age of onset was two, 2 months with a range
from 1 to 7.
Among gastrointestinal problems, dysphagia was
present in 61 % of cases (with mild degree in the
half of cases) and constipation in about the 76 %.
Only a small subgroup presented a severe sleep
disorder while the majority had only a mild
impairment.
The cardiorespiratory phenotype was forced in the
majority of cases. No Feeble phenotype was found [9].
Discussion
The present study was conducted on a population of in-
dividuals with Rett syndrome who regularly attended the
Tuscany Rett Center. The majority of the cohort is rep-
resented by girls living in the same region, but we ac-
count a considerable number of girls, and even males
with Rett syndrome, coming from various parts of Italy.
Hence this is the first study conducted in Italy on a
large, unbiased, group of individuals affected by this
condition.
The cohort has classic cases as well as variants [4]. We
account for a considerable percentage of atypical forms
(35 %), greater than data reported in the literature, in-
cluded between 15 and 30 % [24–26]. MECP2 mutations
were present in almost all classical and Z-RTT cases, a
notable link between these cases where clinical features
slowly change from one end to another. The ARTT-
NOS show different kind of genetic abnormalities in
only 30 % of the cases.
All individuals fulfilled the diagnostic criteria for Rett
Syndrome in the classical form or variants: all individ-
uals had a delay in development, different degree of re-
gression and an autistic phase. In 20 % of cases autistic
traits were marked even years after diagnosis. The sam-
ple consisted of 151 individuals (all females except 2
cases), of which 132 subjects with genetic mutations:
118 with MECP2 mutations; 12 with CDKL5 mutations
2 with FOXG1 and MEF2C mutations. For 19 individuals
with clinical diagnosis (12.5 %) no genetic mutation was
identified.
Considering the clinical symptoms described in classic
cases and in those with the preserved speech variant
(Z-RTT) and the corresponding MECP2 mutations, we
observed a parallel, progressive sequence in the severity of
symptoms, concerning the terminal C deletion in several
cases of Z-RTT variant and in a more limited number of
classic cases only. Somatic features varied from a minor
signs in classic cases to normal physical appearance
in Z-RTT; scoliosis followed the same pattern and the
same applies to the ability to walk and the use of hands.









Mean (SD) 5.5 (2.1) 5.6 (2.4) 9.2 (8.1) 9,2 (8,1)
Range 0.9–9.4 1.2–116 3.5–15 3.5–15
Table 21 Clinical forms and genes
Classical Atypical Total
Hanefeld Congenital Z-RTT ARTT-NOS
RTT male MECP2 + – – – – 2/20 (10 %) 2
RTT females MECP2 + 94/98 (96 %) – – 18/19 (95 %) 4/20 (20 %) 116
RTT females MECP2- 4/98 (4 %) – – 1/19 (5 %) 13/20 (65 %) 18
CDKL5 + – 12 – – – 12
CDKL5-e MECP2- 1 1
FOXG1 + – – 1 – – 1
MEF2C + – – – – 1/20 (5 %) 1
TOTAL 98 (100 %) 13 (100 %) 1 19 (100 %) 20 (100 %) 151
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Hand stereotypic activities (‘hand washing’) were intense
and present all day in the waking state in classic individ-
uals and became occasional in Z-RTT; the same applies to
epilepsy as well as to cardiac and breathing abnormalities,
more frequent and intense in severe cases and less pro-
nounced in those with some speaking ability. In contrast,
we observed that intensity of general anxiety is inversely
correlated with clinical severity [27]. In all these cases a
constant regression followed an initial period (several
months) when the toddler did not show clear signs of ab-
normality and was usually considered to be normal by
parents although abnormalities of General Movements
could be detected by professionals [28, 29]. In the present
study Z-RTT was more frequently observed (12.6 %) than
in previous studies as, for example, only 3 out of 168 indi-
viduals in Spain [30].
It has recently reported [31] that most cases of FOXG1
mutation have structural brain abnormalities including
corpus callosum malformation, present also in the only
congenital case of the present study. The study suggests
that this is a distinct clinical entity with different fea-
tures and the hypothesis is further supported by lack of
scoliosis and an entirely different clinical course. In these
cases symptoms appear soon after birth and, in contrast
with classical and Z-RTT, don’t have a regression. Some
authors associate these cases to the dyskinetic encephal-
opathy of infancy [32]. A similar suggestion has been
made for the early seizure variant (Hanelfeld) with a dif-
ferent clinical appearance where females present minore
frequenza of scoliosis and a persistent gaze avoidance; in
addition, in most girls regression occurs in the context of
severe seizures. This is different from typical Rett, rare
MECP2 mutations and in most case a different mutation
CDKL5, data which correspond to a large extent to what
has been observed in the present study [33, 34].
In our sample we considered both the age of the
evaluation and the age of diagnosis: this data are a meas-
ure of the time required to make the diagnosis of Rett
syndrome, which is different for each clinical form [33],
and not necessarily directly correlated to the age of on-
set of symptoms, but is linked to the complexity of the
diagnosis. Important symptoms such as developmental
delay, absence and / or loss of language, presence of ste-
reotypies and eating disorders favour the early diagnosis;
absence of stereotypies, presence of language, autistic
traits and mild motor disorders, lead specialists to in-
corporate these cases into broader diagnostic categories
such as mental retardation or autism and contribute to
delay the correct diagnosis [26], similarly to what ob-
served in atypical presentations [35]. In our study, the
frequency of labeled autistic traits was present in the
20 % of individuals.
Autonomic nervous system (ANS)
A major contribution of this study is connected to the
attention paid to disorders of the autonomic nervous
system, which are present in all clinical forms, although
with some variability.
Imbalances of ANS, essentially characterized by a vagal
tone comparable to that of a newborn and therefore par-
ticularly immature [17] implies a constant imbalance of
sympathetic parasympathetic activity in favour of the lat-
ter and determines the following symptoms: impaired
swallowing, abnormalities in the gastro-esophageal tract
and urinary bladder, mood disorders, sleep disorders,
peripheral circulation in the limbs and abnormalities of
breathing frequency.
All clinical forms presented massive respiratory dys-
functions which, although with great variability across
single cases, affected 50 % of the whole registration time
for the classic forms and 40 % of the Z-Rett and RTT-
NOS individuals. The other two variants had higher
values: 57.1 % in Hanefeld’ s and 37.4 % in the congeni-
tal forms; these differences were not statistically
significant.
We found cardiorespiratory abnormalities in all our
subjects with classic RTT, with the exception of one sin-
gle case, and two females in the ART-NOS group. The
Valsalva maneuver is present in the classical forms and
represents 5.5 % of all respiratory abnormalities; in the
Table 23 ISS total score and MECP2 mutations












Mean (SD) 21.3 (6.2) 16.7 (4.7) 19.2 (5.9) 20.3 (7) 18.4 (5.7) 14.2 (6)
Table 22 MECP2 mutations and clinical forms
Mutations Classical Atypical Tot %
Z-RTT ARTT-NOS
Substitutions
Non sense 29 1 1 31 26 %
Early truncating 22 – 1 23
Late truncating 7 1 – 8
Missense 29 9 4 42 36 %
Large Deletions 17 – – 17 14 %
Frameshift 19 8 1 28 24
C terminal deletions 12 7 – 19
94 18 6 118 100 %
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Z-Rett the maneuver is almost always absent (0.5 %).
There were no differences for HR, CVT, and blood gases
that depend more on the cardiorespiratory phenotype
than on the clinical form. For the CVT analysis, the
study showed high values in individuals with forceful
breathing (never described in literature observation). In
particular, the values of vagal tone (CVT) in the individ-
uals with forceful were closer to the control values than
the CVT of the other individuals. Heart rate, on the con-
trary, did not show significant differences across differ-
ent phenotypes [17].
The comparison of cardiorespiratory phenotypes
showed higher levels of PCO2 in feeble and in apneustic
phenotype than in forced phenotype. This observation
has particularly important neurophysiological implica-
tions, both in the event of general anesthesia and in
cases where, in the worsening of the respiratory disorder,
the organism generates a pathological change of the
CO2 (either an increase, or a reduction: hypo- and hy-
percapnia) [18].
Gastrointestinal phenotype was compromised, and se-
vere feeding disorders required in some cases the use of
some devices, like percutaneous endoscopic gastrostomy
(PEG), useful for long period of time, or the nasogastric
tube, for short period of time [36]. In our study, the use
of PEG was limited to 3 cases.
To further define the differences in the symptoms re-
lated to ANS between the clinical forms, we considered
sleep. The prevalence of sleep disorders is particularly
high in Rett population, in order of 80 % [37]; daytime
napping, night-time laughter, teeth grinding, screaming
and night awakenings due to the appearance of seizures
were the most frequently reported problems. The major
problems were related to difficulty falling asleep or
night-time/early morning awakenings. In our cases, the
measurement time, representing 38 % was more fre-
quently associated with Hanefeld through against the
classic forms and Z-Rett.
Comparison between scoring systems ISS and PBZ:
the ISS highlights the reduced impairment of Z-Rett
compared to all other forms with statistically significant
differences in the overall assessment, as in growth and
development area, in the muscle skeletal, in the area of
movement and in the cortex. However, it does not show
significant differences across all other dependent forms
of the Autonomic Nervous System, in contrast to what
reported in literature (see Table 12).
The results obtained with the two scoring systems ISS
and PBZ are comparable, and PBZ evaluation allowed an
evaluation of the daily living. The PBZ is a scale of evalu-
ation designed to test severity in Classical Rett Syndrome
and its variants. The scale is susceptible to recording even
minimal changes in clinical symptoms over the course of
therapy, rehabilitation programmes and environmental
enrichment, but also to indicating the severity of different
clinical and genetic groups [14]. The evaluation with PBZ
scoring system showed a worse clinical presentation for
Hanefeld variant; daily living evaluation greatly contrib-
uted to the evaluation of the phenotype. Even with the
PBZ system the Z-Rett was the mildest form in our cohort
for all the areas considered. All the reported differences
were significant in each area.
In general, the PBZ scale allows a more sophisticated
classification. In fact ISS system allows only two values
for defining the cognitive level and language: severe and
extreme, but it does not accept that there is no sign of
Rett, even though there are some females with Z-Rett,
with a good speech and motor performance.
Both PBZ and ISS scales showed a better score for the
auxological parameters in the Z-Rett and Hanefeld girls,
for all the considered parameters (height, weight, and
OFC). The BMI values were significantly different in
favour of any other forms, Hanefeld included. The BMI
did not correlate to the clinical form, but was associated
with cardio-respiratory phenotype: this is consistent with
an association between low BMI and forced phenotype
because of the energy consumption in this phenotype.
The data are consistent with those reported in the litera-
ture: mean weight, height, and BMI z scores in subjects
with Rett syndrome were below that of their age group
and decreased at steadily with age [38].
Cortical activity is clearly related to the onset and sever-
ity of epilepsy. Epilepsy was present in 64.2 % of the cases,
a value close to the 68.1 % reported from the Rett network
database. Drug resistant cases were less frequent: 17.2 %
compared to 32.2 % of the above quoted study [39] pos-
sibly related to a comparatively greater number of Z-RTT
girls where drug resistant epilepsy in unusual. Also, the
onset of epilepsy occurs earlier in Hanefeld. In all the fe-
males with CDKL5 mutation presented major sleep dis-
ruptions compared to other forms: RTT versus other
forms: χ2 test = 83.399; p = 0.0001; ARTT-NOS vs Hanefeld
vs classical vs congenita: χ2 test = 4.82; p = 0.18 not signifi-
cant. It is possible that in our cohort, the higher number of
Table 24 PBZ total score and MECP2 mutations












Mean (SD) 34.4 (13.5) 33.4 (9.3) 38.2 (8.8) 42.7 (11.6) 32.6 (9.9) 23.4 (12)
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Z-Rett girls justify some of the differences observed be-
tween our and other classifications- for example, the resist-
ant epilepsy described by Krajnc [40].
Finally, all clinical forms considered were indistin-
guishable from each other as regards the ANS in-
volvement, but overall the scales used confirmed that
the Z-RTT had milder phenotype if compared to all the
other forms, and have the best quality of life as assessed
with the PBZ (χ2 test = 25.04; p < 0.01).
Genetic analysis showed that there is a correlation be-
tween gene involved and different clinical forms but there
is a weak correlation between the severity of the pheno-
type and type of mutation, except for C-Terminal deletion
that were statistically associated with clinical forms with
the lowest scores of severity scales (ISS and PBZ) in ac-
cordance with what is reported in the literature [41, 42].
Conclusions
The present study confirms the variability of Rett
clinical phenotype and adds new autonomic and an-
thropometric variables to clinical data with better re-
sults in the Z-RTT girls. Autonomic abnormalities were
common in the classical form and present also in a num-
ber of cases of the preserved speech variant. In this respect
it must be noticed that abnormalities of this kind are com-
mon also in other neurodevelopmental disorders and have
been described in Autistic Spectrum Disorders [11].
In our cohort we found a broad variety of RTT clinical
forms. In the great majority of individuals with classical
form and preserved speech variant there was a mutation
in the MECP2 gene with a correlation between clinical
evaluation and genetic analysis. Almost all cases of
Hanefeld variant had a CDKL5 mutation. There was only
one case of the congenital form.
An analysis of the MECP2 mutations, showed that C-
terminal mutations were associated to milder clinical forms
and lower scores in severity scales (ISS and PBZ), confirm-
ing what has been observed in other studies [41, 42].
However, considered the spectrum of all MECP2 mu-
tations, females with the Z-Rett variant present a milder
phenotype and severity seems to be related to the early
development of the disorder, suggesting that the natural
history of the disease is dependent to the stage of regres-
sion: absent or reduced.
The frequency of epilepsy was not different across dif-
ferent clinical forms, although we did not find any pa-
tient with drug-resistant epilepsy in the Z-Rett females.
Other authors report a decreased frequency of epilepsy
in Z-Rett, but in our cohort the number of females with
Z-Rett was higher than in other studies and this can in-
fluence the final outcome [39, 40].
We did not find significant correlation between clinical
forms and cardio-respiratory phenotype: however, the
forced breathing phenotype was associated to a reduced
BMI, suggesting that the high energetic cost of this ab-
normal breathing leads to a chronic hypoxia.
The breathing abnormalities are not typical of Rett
syndrome, however the breathing patterns are an essen-
tial element of the diagnosis, for example, the evaluation
of the ANS allows the distinction between non-epileptic
paroxysm and epilepsy, contributes to the diagnosis in
MECP2 negative forms, allows to design a personalized
therapy [17], and eventually, taking into account all the
limitations, a better prognosis.
Similarly, we did not find a significant correlation be-
tween clinical form and cardio-respiratory phenotype,
however the forceful breathing phenotype was associated
to high CVT values and to a reduced BMI suggesting that
the high energetic cost of this abnormal breathing leads to
a chronic hypoxia. The non-invasive assessment of brain-
stem function in Rett may contribute to life-long clinical
management and might be as important as the genotype
in understanding the pathology and in prognostication.
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